TXNRD1 promotes tumor growth, DNA replication, and tumorigenicity [16, 17], and knockdown of TXNRD1 also increases sensitivity of cancer cells to some chemotherapy drugs [18, 19]; these finding suggest it is a potential target for anticancer agents [20]. Here, TXNRD1 is linked to neoplasm.